Betta Pharmaceuticals Co (SZSE:300558) Ending Cash Position : ¥554 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Ending Cash Position?

Betta Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥554 Mil.

Betta Pharmaceuticals Co's quarterly Ending Cash Position increased from Sep. 2023 (¥694 Mil) to Dec. 2023 (¥752 Mil) but then declined from Dec. 2023 (¥752 Mil) to Mar. 2024 (¥554 Mil).

Betta Pharmaceuticals Co's annual Ending Cash Position declined from Dec. 2021 (¥792 Mil) to Dec. 2022 (¥731 Mil) but then increased from Dec. 2022 (¥731 Mil) to Dec. 2023 (¥752 Mil).

Betta Pharmaceuticals Co Ending Cash Position Historical Data

The historical data trend for Betta Pharmaceuticals Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Ending Cash Position Chart

Betta Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

521.30

1,345.95

791.99

731.29

752.00

Betta Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															584.97	663.11	694.31	752.00	554.02

Betta Pharmaceuticals Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Betta Pharmaceuticals Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	731.285	+	20.712
	=	752

Betta Pharmaceuticals Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	751.995	+	-197.975
	=	554

Betta Pharmaceuticals Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Betta Pharmaceuticals Co (SZSE:300558) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

No.355, Xingzhong Road, Yuhang Economic and Technological Development Zone, Zhejiang Province, Hangzhou, CHN

Website

http://www.bettapharma.com

Betta Pharmaceuticals Co Ltd is a hi-tech pharmaceutical enterprise focuses on research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates through China.

Executives

Wang Jia Bing	Directors, executives
Ding Lie Ming	Directors, executives
Cai Wan Yu	Executives

Betta Pharmaceuticals Co (SZSE:300558) Headlines

No Headlines